Office of The Director, National Institutes of Health; Amended Notice of Meeting, 48154 [2019-19692]
Download as PDF
<![CDATA[
48154
Federal Register / Vol. 84, No. 177 / Thursday, September 12, 2019 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the CDC/HRSA Advisory
Committee on HIV, Viral Hepatitis and
STD Prevention and Treatment
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC)/HRSA Advisory
Committee on HIV, Viral Hepatitis and
STD Prevention and Treatment (CHAC)
has scheduled a public meeting.
Information about CHAC can be found
on the CHAC website at https://
www.cdc.gov/maso/facm/
facmCHACHSPT.html. Meeting
information and the agenda can be
found at https://www.chachspt.com.
DATES: November 13, 2019, 8:30 a.m.–
5:00 p.m. Eastern Time (ET) and
November 14, 2019, 8:30 a.m.–3:00 p.m.
Eastern Time (ET).
ADDRESSES: This meeting will be held
in-person and by webinar. The address
for the meeting is 5600 Fishers Lane,
Rockville, Maryland 20857. While this
meeting is open to the public, advance
registration is required to attend inperson. Please visit the meeting
information website to register: https://
www.chachspt.com. The deadline for
online registration is 12:00 p.m. ET on
November 6, 2019. To access the
meeting virtually, please use the
information below. Registration is
encouraged, but not required, for virtual
attendance.
• Webinar link: https://
hrsa.connectsolutions.com/fall-2019chac-meeting/
• Conference call-in number: 888–469–
0878 Passcode: 8802805
FOR FURTHER INFORMATION CONTACT:
Theresa Jumento, Senior Public Health
Advisor, HIV/AIDS Bureau, HRSA, 5600
Fishers Lane, Rockville, Maryland
20857; 301–443–5807; or
CHACAdvisoryComm@hrsa.gov.
SUPPLEMENTARY INFORMATION: CHAC was
established under Section 222 of the
Public Health Service Act, [42 U.S.C.
Section 217a], as amended.
The purpose of CHAC is to advise the
Secretary, HHS; the Director, CDC; and
the Administrator, HRSA regarding
objectives, strategies, policies, and
priorities for HIV, viral hepatitis, and
other STDs; prevention and treatment
jbell on DSK3GLQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:27 Sep 11, 2019
Jkt 247001
efforts including surveillance of HIV
infection, viral hepatitis, and other
STDs, and related behaviors;
epidemiologic, behavioral, health
services, and laboratory research on
HIV, viral hepatitis, and other STDs;
identification of policy issues related to
HIV/viral hepatitis/STD professional
eduction, patient healthcare delivery,
and prevention services; Agency
policies about prevention of HIV, viral
hepatitis and other STDs; treatment,
healthcare delivery, and research and
training; strategic issues influencing the
ability of CDC and HRSA to fulfill their
missions of providing prevention and
treatment services; programmatic efforts
to prevent and treat HIV, viral hepatitis,
and other STDs; and support to the
Agencies in their developoment of
responses to emerging health needs
related to HIV, viral hepatitis, and other
STDs.
During the November 13–14, 2019
meeting, CHAC will discuss issues
related to the President’s initiative on
‘‘Ending the HIV Epidemic: A Plan for
America,’’ building community
capacity, strategies for engaging people
with HIV who are out of care, models
of clinical care, workforce issues, preexposure prophylaxis services in
community health centers, and pending
committee reports. Agenda items are
subject to change as priorities dictate.
Refer to the CHAC meeting information
website for any updated information
concerning the meeting.
Members of the public will have the
opportunity to provide comments.
Requests to offer oral comments will be
accepted in the order they are received
and may be limited as time allows.
Public participants may also submit
written statements as further described
below. To submit written comments or
to request time for an oral comment at
the meeting, please register online by
12:00 p.m. ET on November 6, 2019. For
additional details, visit the meeting
information website at https://
www.chachspt.com. Individuals who
plan to attend and need special
assistance or another reasonable
accommodation should notify Theresa
Jumento at the address and phone
number listed above at least 10 business
days prior to the meeting. Since this
meeting occurs in a federal government
building, attendees must go through a
security check to enter the building.
Non-U.S. Citizen attendees must notify
HRSA of their planned attendance at
least 20 business days prior to the
meeting in order to facilitate their entry
into the building. All attendees are
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
required to present government-issued
identification prior to entry.
Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2019–19776 Filed 9–11–19; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of The Director, National
Institutes of Health; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the Advisory Committee
on Research on Women’s Health,
October 23, 2019, 09:00 a.m. to October
23, 2019, 04:30 p.m., National Institutes
of Health, Natcher Building, Conference
Room E1/E2, 45 Center Drive, Bethesda,
MD 20892 which was published in the
Federal Register on February 08, 2019,
84 FR 2895.
The meeting notice is amended to
update the agenda description to
include a discussion on the
development of a challenge prize for
enhancing faculty gender equity and
diversity in biomedical sciences. The
discussion will include the following
topics: Clarifying the goal and fit with
a prize model; defining measures of
institutional faculty gender equity and
diversity; framing challenge description
for a broad applicant pool; judging
criteria; and identifying barriers.
The meeting is open to the public.
Dated: September 6, 2019.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–19692 Filed 9–11–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
General Medical Sciences Council.
The meeting will be open to the
public as indicated below, with a short
public comment period at the end.
Attendance is limited by the space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
E:\FR\FM\12SEN1.SGM
12SEN1
]]>Agencies
[Federal Register Volume 84, Number 177 (Thursday, September 12, 2019)]
[Notices]
[Page 48154]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-19692]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of The Director, National Institutes of Health; Amended
Notice of Meeting
Notice is hereby given of a change in the meeting of the Advisory
Committee on Research on Women's Health, October 23, 2019, 09:00 a.m.
to October 23, 2019, 04:30 p.m., National Institutes of Health, Natcher
Building, Conference Room E1/E2, 45 Center Drive, Bethesda, MD 20892
which was published in the Federal Register on February 08, 2019, 84 FR
2895.
The meeting notice is amended to update the agenda description to
include a discussion on the development of a challenge prize for
enhancing faculty gender equity and diversity in biomedical sciences.
The discussion will include the following topics: Clarifying the goal
and fit with a prize model; defining measures of institutional faculty
gender equity and diversity; framing challenge description for a broad
applicant pool; judging criteria; and identifying barriers.
The meeting is open to the public.
Dated: September 6, 2019.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-19692 Filed 9-11-19; 8:45 am]
BILLING CODE 4140-01-P
